FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Sarepta Completes Confirmatory Duchenne Trial

Sarepta Therapeutics reports mixed data from its Phase 3 ESSENCE confirmatory study evaluating its Duchenne muscular dystrophy drugs Amondys 45 (casim...

latest-news-card-1
Human Drugs

Compass Pathways Speeds COMP360 Launch

Compass Pathways says it expects to be able to launch its COMP360 psilocybin treatment for treatment-resistant depression nine to 12 months sooner tha...

latest-news-card-1
Human Drugs

Otsuka ICU Recalls Mislabeled Potassium Chloride Injection

Otsuka ICU Medical recalls (Class 1) one lot of its potassium chloride injection, 20 mEq, after discovering that the overwrap label was incorrectly pr...

latest-news-card-1
Medical Devices

FDA OKs Aqua Medical IDE for Endoscopic Technology Trial

FDA gives investigative device exemption approval for an Aqua Medical pilot clinical trial of its Proximal Intestinal Mucosal Ablation system to treat...

latest-news-card-1
Human Drugs

Reforms Needed to Boost Efficiency of Global Cancer Trials: Report

A new report from the Reagan-Udall Foundation calls for broad operational and policy reforms to improve the efficiency, representativeness, and succes...

latest-news-card-1
Human Drugs

FDA OKs Meitheals Antibiotic for Urinary Tract Infections

FDA approves a Meitheal Pharmaceuticals NDA for Contepo (fosfomycin) for injection for treating adults with complicated urinary tract infections.

latest-news-card-1
Human Drugs

Lawsuit Against Tidmarsh Paints Troubling Picture

Aurinia Pharmaceuticals lawsuit against CDER director George Tidmarsh includes screenshots of troubling text messages and emails from Tidmarsh to Kevi...

latest-news-card-1
Human Drugs

Top Drug Chief Resigns Amid Misconduct Probe, Lawsuit

CDER director George Tidmarsh resigns after being placed on administrative leave amid an internal ethics investigation and a defamation lawsuit tied t...

latest-news-card-1
Human Drugs

Drug for Ultra-Rare Mitochondrial Disease Approved

FDA approves UCBs Kygevvi (doxecitine and doxribtimine) for treating thymidine kinase 2 deficiency.

latest-news-card-1
Human Drugs

FDA Lifts Hold on Rein Pulmonary Fibrosis Trial

FDA lifts a clinical hold against the Rein Therapeutics Phase 2 RENEW trial evaluating LTI-03 in patients with idiopathic pulmonary fibrosis.